news_6

Seagen and Astellas Announce Submission of Two Supplemental Biologics License Applications to the U.S. FDA for PADCEV® (enfortumab vedotin-ejfv) in Locally Advanced or Metastatic Urothelial Cancer

news_6

Asia-Pacific Sports Medicine Markets, 2020-2030: Product (Repair, Recovery, Monitoring, Accessories), & Application (Knee, Shoulder, Hip) – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Sports Medicine Market 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End User, and...